This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cornelissen, M.
Right arrow Articles by Goudsmit, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cornelissen, M.
Right arrow Articles by Goudsmit, J.

 Previous Article  |  Next Article 

J. Virol., Sep 1997, 6348-6358, Vol 71, No. 9
Copyright © 1997, American Society for Microbiology

pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D

M Cornelissen, R van den Burg, F Zorgdrager, V Lukashov and J Goudsmit
Department of Human Retrovirology, Academic Medical Centre, Amsterdam, The Netherlands. M.I.Cornelissen@amc.uva.nl

Naturally occurring mutations in the polymerase gene of human immunodeficiency virus type 1 (HIV-1) have important implications for therapy and the outcome of clinical studies. Using 42 virus isolates obtained from the UNAIDS sample collection, we analyzed the protease (99 amino acids [aa]) and the first 297 aa of reverse transcriptase (RT) coding regions. Based on the V3 sequence analysis, the collection includes subtype A (n = 5), subtype B (n = 12), subtype C (n = 1), subtype D (n = 11), and subtype E (n = 13) viruses. Of the 42 protease genes, 37 contained naturally occurring mutations at positions in the gene that contribute to resistance to protease inhibitors (indinavir, saquinavir, ritonavir, and nelfinavir) in clade B isolates. The phenotypic effect of these substitutions in non-B isolates is unclear. The The 5'half RT coding region of the 42 isolates was found to be less variable, although 19 of the 42 RT sequences contained amino acid substitutions known to contribute to nucleoside and/or nonnucleoside drug resistance. Since the virus isolates were obtained in 1992, it is unlikely that the infected subjects received protease inhibitors, but we found evidence that one subject acquired a zidovudine (AZT)- resistant HIV-1 strain from a contact who had received AZT. Phylogenetic analysis identified five subtype pol clusters: A, B, C, D, and A'. Comparison of env and pol sequences of the same viruses showed no more recombination events than were already identified on the basis of gag/env comparison (M. Cornelissen, G. Kampinga, F. Zorgdrager, J. Goudsmit, and the UNAIDS Network for HIV Isolation and Characterization, J. Virol. 70:8209-8212, 1996). In one of the known recombinants, a crossover site between subtypes A and C could be identified, and in another, a crossover site could not be identified due to lack of a reference subtype F pol sequence. We analyzed the ds/da ratio of gag, pol, and env sequences of 35 isolates, excluding the recombinants. Our analysis showed that gag and pol are subjected to purifying selection with an average ds/da ratio above 1, independent of the subtype and in contrast with V3 (ds/da approximately 1). Based on the low ds/da ratio of the intergroup analysis of A/E and B/D gag and pol sequences, we analyzed the evolutionary relation between subtypes B and D in more detail by constructing separate phylogenetic trees for synonymous and nonsynonymous substitutions. Our analysis suggests a common ancestry for subtypes B and D that is distinct from that of subtypes A and E.


This article has been cited by other articles:

  • Kearney, M., Maldarelli, F., Shao, W., Margolick, J. B., Daar, E. S., Mellors, J. W., Rao, V., Coffin, J. M., Palmer, S. (2009). Human Immunodeficiency Virus Type 1 Population Genetics and Adaptation in Newly Infected Individuals. J. Virol. 83: 2715-2727 [Abstract] [Full Text]  
  • Taiwo, B. O., Murphy, R. (2007). Transmitted Resistance: An Overview and Its Potential Relevance to the Management of HIV-Infected Persons in Resource-Limited Settings. J Int Assoc Physicians AIDS Care (Chic Ill) 6: 188-197 [Abstract]  
  • Held, D. M., Kissel, J. D., Thacker, S. J., Michalowski, D., Saran, D., Ji, J., Hardy, R. W., Rossi, J. J., Burke, D. H. (2007). Cross-Clade Inhibition of Recombinant Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus SIVcpz Reverse Transcriptases by RNA Pseudoknot Aptamers. J. Virol. 81: 5375-5384 [Abstract] [Full Text]  
  • Gatanaga, H., Das, D., Suzuki, Y., Yeh, D. D., Hussain, K. A., Ghosh, A. K., Mitsuya, H. (2006). Altered HIV-1 Gag Protein Interactions with Cyclophilin A (CypA) on the Acquisition of H219Q and H219P Substitutions in the CypA Binding Loop. J. Biol. Chem. 281: 1241-1250 [Abstract] [Full Text]  
  • Hirigoyen, D. L., Cartwright, C. P. (2005). Use of Sequence Data Generated in the Bayer TruGene Genotyping Assay To Recognize and Characterize Non-Subtype-B Human Immunodeficiency Virus Type 1 Strains. J. Clin. Microbiol. 43: 5263-5271 [Abstract] [Full Text]  
  • Geels, M. J., Dubey, S. A., Anderson, K., Baan, E., Bakker, M., Pollakis, G., Paxton, W. A., Shiver, J. W., Goudsmit, J. (2005). Broad Cross-Clade T-Cell Responses to Gag in Individuals Infected with Human Immunodeficiency Virus Type 1 Non-B Clades (A to G): Importance of HLA Anchor Residue Conservation. J. Virol. 79: 11247-11258 [Abstract] [Full Text]  
  • Weber, J., Chakraborty, B., Weberova, J., Miller, M. D., Quinones-Mateu, M. E. (2005). Diminished Replicative Fitness of Primary Human Immunodeficiency Virus Type 1 Isolates Harboring the K65R Mutation. J. Clin. Microbiol. 43: 1395-1400 [Abstract] [Full Text]  
  • Geels, M. J., Cornelissen, M., Schuitemaker, H., Anderson, K., Kwa, D., Maas, J., Dekker, J. T., Baan, E., Zorgdrager, F., van den Burg, R., van Beelen, M., Lukashov, V. V., Fu, T.-M., Paxton, W. A., van der Hoek, L., Dubey, S. A., Shiver, J. W., Goudsmit, J. (2003). Identification of Sequential Viral Escape Mutants Associated with Altered T-Cell Responses in a Human Immunodeficiency Virus Type 1-Infected Individual. J. Virol. 77: 12430-12440 [Abstract] [Full Text]  
  • Spira, S., Wainberg, M. A., Loemba, H., Turner, D., Brenner, B. G. (2003). Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity and drug resistance. J Antimicrob Chemother 51: 229-240 [Abstract] [Full Text]  
  • Ball, S. C., Abraha, A., Collins, K. R., Marozsan, A. J., Baird, H., Quinones-Mateu, M. E., Penn-Nicholson, A., Murray, M., Richard, N., Lobritz, M., Zimmerman, P. A., Kawamura, T., Blauvelt, A., Arts, E. J. (2002). Comparing the Ex Vivo Fitness of CCR5-Tropic Human Immunodeficiency Virus Type 1 Isolates of Subtypes B and C. J. Virol. 77: 1021-1038 [Abstract] [Full Text]  
  • Brindeiro, P. A., Brindeiro, R. M., Mortensen, C., Hertogs, K., De Vroey, V., Rubini, N. P. M., Sion, F. S., De Sa, C. A. M., Machado, D. M., Succi, R. C. M., Tanuri, A. (2002). Testing Genotypic and Phenotypic Resistance in Human Immunodeficiency Virus Type 1 Isolates of Clade B and Other Clades from Children Failing Antiretroviral Therapy. J. Clin. Microbiol. 40: 4512-4519 [Abstract] [Full Text]  
  • Quinones-Mateu, M. E., Gao, Y., Ball, S. C., Marozsan, A. J., Abraha, A., Arts, E. J. (2002). In Vitro Intersubtype Recombinants of Human Immunodeficiency Virus Type 1: Comparison to Recent and Circulating In Vivo Recombinant Forms. J. Virol. 76: 9600-9613 [Abstract] [Full Text]  
  • Loemba, H., Brenner, B., Parniak, M. A., Ma'ayan, S., Spira, B., Moisi, D., Oliveira, M., Detorio, M., Wainberg, M. A. (2002). Genetic Divergence of Human Immunodeficiency Virus Type 1 Ethiopian Clade C Reverse Transcriptase (RT) and Rapid Development of Resistance against Nonnucleoside Inhibitors of RT. Antimicrob. Agents Chemother. 46: 2087-2094 [Abstract] [Full Text]  
  • Lukashov, V. V., Goudsmit, J. (2002). Evolutionary relationships among Astroviridae. J. Gen. Virol. 83: 1397-1405 [Abstract] [Full Text]  
  • Shafer, R. W. (2002). Genotypic Testing for Human Immunodeficiency Virus Type 1 Drug Resistance. Clin. Microbiol. Rev. 15: 247-277 [Abstract] [Full Text]  
  • Thomson, M. M., Delgado, E., Herrero, I., Villahermosa, M. L., Vazquez-de Parga, E., Cuevas, M. T., Carmona, R., Medrano, L., Perez-Alvarez, L., Cuevas, L., Najera, R. (2002). Diversity of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences. J. Gen. Virol. 83: 107-119 [Abstract] [Full Text]  
  • Lukashov, V. V., Goudsmit, J. (2001). Evolutionary Relationships among Parvoviruses: Virus-Host Coevolution among Autonomous Primate Parvoviruses and Links between Adeno-Associated and Avian Parvoviruses. J. Virol. 75: 2729-2740 [Abstract] [Full Text]  
  • Vergne, L., Peeters, M., Mpoudi-Ngole, E., Bourgeois, A., Liegeois, F., Toure-Kane, C., Mboup, S., Mulanga-Kabeya, C., Saman, E., Jourdan, J., Reynes, J., Delaporte, E. (2000). Genetic Diversity of Protease and Reverse Transcriptase Sequences in Non-Subtype-B Human Immunodeficiency Virus Type 1 Strains: Evidence of Many Minor Drug Resistance Mutations in Treatment-Naive Patients. J. Clin. Microbiol. 38: 3919-3925 [Abstract] [Full Text]  
  • Sato, H., Tomita, Y., Shibamura, K., Shiino, T., Miyakuni, T., Takebe, Y. (2000). Convergent Evolution of Reverse Transcriptase (RT) Genes of Human Immunodeficiency Virus Type 1 Subtypes E and B following Nucleoside Analogue RT Inhibitor Therapies. J. Virol. 74: 5357-5362 [Abstract] [Full Text]  
  • Cornelissen, M., van den Burg, R., Zorgdrager, F., Goudsmit, J. (2000). Spread of distinct human immunodeficiency virus type 1 AG recombinant lineages in Africa. J. Gen. Virol. 81: 515-523 [Abstract] [Full Text]  
  • Yahi, N., Tamalet, C., Tourrès, C., Tivoli, N., Ariasi, F., Volot, F., Gastaut, J.-A., Gallais, H., Moreau, J., Fantini, J. (1999). Mutation Patterns of the Reverse Transcriptase and Protease Genes in Human Immunodeficiency Virus Type 1-Infected Patients Undergoing Combination Therapy: Survey of 787 Sequences. J. Clin. Microbiol. 37: 4099-4106 [Abstract] [Full Text]  
  • Brindeiro, R., Vanderborght, B., Caride, E., Correa, L., Oravec, R. M., Berro, O., Stuyver, L., Tanuri, A. (1999). Sequence Diversity of the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 from Untreated Brazilian Individuals. Antimicrob. Agents Chemother. 43: 1674-1680 [Abstract] [Full Text]  
  • Koch, N., Yahi, N., Ariasi, F., Fantini, J., Tamalet, C. (1999). Comparison of Human Immunodeficiency Virus Type 1 (HIV-1) Protease Mutations in HIV-1 Genomes Detected in Plasma and in Peripheral Blood Mononuclear Cells from Patients Receiving Combination Drug Therapy. J. Clin. Microbiol. 37: 1595-1597 [Abstract] [Full Text]  
  • Grassly, N. C., Harvey, P. H., Holmes, E. C. (1999). Population Dynamics of HIV-1 Inferred From Gene Sequences. Genetics 151: 427-438 [Abstract] [Full Text]  
  • Boden, D., Markowitz, M. (1998). Resistance to Human Immunodeficiency Virus Type 1 Protease Inhibitors. Antimicrob. Agents Chemother. 42: 2775-2783 [Full Text]  
  • Velazquez-Campoy, A., Todd, M. J., Vega, S., Freire, E. (2001). Catalytic efficiency and vitality of HIV-1 proteases from African viral subtypes. Proc. Natl. Acad. Sci. USA 98: 6062-6067 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»